Michael Wang, MD
Anatomic Pathology & Clinical Pathology · Columbia, MONPI 1073550794
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $172 of the $194 with a category attached, or 89.0%. 5 manufacturers reported payments, led by Novartis at 56.0% of the total.
Across 5 payments — averaging $38.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$109
- Tesaro, Inc.$27
- Biofrontera Inc.$24
- AMAG Pharmaceuticals, Inc.$21
- Incyte Corporation$12
Across 2 payments — averaging $50,773 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Incyte Corporation$102K
What the payments were for
- Food & beverage$17289%
- Education$2111%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 1 | $109 |
| Tesaro, Inc. | 1 | $27 |
| Biofrontera Inc. | 1 | $24 |
| AMAG Pharmaceuticals, Inc. | 1 | $21 |
| Incyte Corporation | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PIQRAY$109
How this compares
$194 in reported general payments places this provider in the 70th percentile of 169 anatomic pathology & clinical pathology providers in Missouri.
See all anatomic pathology & clinical pathology providers in Missouri →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anatomic pathology & clinical pathology in Columbia
- Alan LugerColumbia$88K
- Carla CarusoColumbia$357
- van NguyenColumbia$205
- David SmidSpringfield$6.8M
- Samuel CaughronN Kansas City$621K
- Eric DuncavageSaint Louis$112K
- Danielle CarpenterSaint Louis$27K
- John RolloSaint Louis$16K
- Xiuli LiuSaint Louis$16K
- Jon RitterSaint Louis$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.